###begin article-title 0
###xml 99 104 <span type="species:ncbi:10090">Mouse</span>
Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer
###end article-title 0
###begin p 1
Conceived and designed the experiments: JH DBU DH. Performed the experiments: JH DBU. Analyzed the data: JH DBU. Contributed reagents/materials/analysis tools: JH LH. Wrote the paper: JH DBU DH.
###end p 1
###begin p 2
Current address: Apoptos Inc., San Diego, California, United State of America
###end p 2
###begin p 3
###xml 465 466 465 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 708 713 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 871 876 868 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1004 1009 1001 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1559 1560 1556 1557 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
Tumor cell death is modulated by an intrinsic cell death pathway controlled by the pro- and anti-apoptotic members of the Bcl-2 family. Up-regulation of anti-apoptotic Bcl-2 family members has been shown to suppress cell death in pre-clinical models of human cancer and is implicated in human tumor progression. Previous gain-of-function studies in the RIP1-Tag2 model of pancreatic islet carcinogenesis, involving uniform or focal/temporal over-expression of Bcl-xL, demonstrated accelerated tumor formation and growth. To specifically assess the role of endogenous Bcl-x in regulating apoptosis and tumor progression in this model, we engineered a pancreatic beta-cell-specific knockout of both alleles of Bcl-x using the Cre-LoxP system of homologous recombination. Surprisingly, there was no appreciable effect on tumor cell apoptosis rates or on tumor growth in the Bcl-x knockout mice. Other anti-apoptotic Bcl-2 family members were expressed but not substantively altered at the mRNA level in the Bcl-x-null tumors, suggestive of redundancy without compensatory transcriptional up-regulation. Interestingly, the incidence of invasive carcinomas was reduced, and tumor cells lacking Bcl-x were impaired in invasion in a two-chamber trans-well assay under conditions mimicking hypoxia. Thus, while the function of Bcl-x in suppressing apoptosis and thereby promoting tumor growth is evidently redundant, genetic ablation implicates Bcl-x in selectively facilitating invasion, consistent with a recent report documenting a pro-invasive capability of Bcl-xL upon exogenous over-expression.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Hanahan1">[1]</xref>
###xml 439 442 439 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Spandidos1">[2]</xref>
###xml 443 446 443 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Lowe1">[4]</xref>
###xml 661 664 661 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Hanahan1">[1]</xref>
###xml 666 669 666 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Hickman1">[5]</xref>
###xml 133 138 <span type="species:ncbi:9606">human</span>
For all cancerous lesions to increase in mass and malignant potential, cell proliferation must outstrip cell death [1]. To this end, human tumors engage or disengage a variety of pathways to escape or minimize apoptosis. The necessity to down-modulate apoptosis also stems from the fact that activating mutations in oncogenes, as well as overexpression of wild-type oncogene alleles, evoke not only hyperproliferation, but also cell death [2]-[4]. A considerable body of evidence supports the proposition that, without some degree of suppression of apoptosis, oncogene-expressing cells cannot progress past relatively small, pre-malignant proliferative lesions [1], [5].
###end p 5
###begin p 6
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 254 264 254 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans</italic>
###xml 296 299 296 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Pegoraro1">[6]</xref>
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Hengartner1">[9]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Cory1">[10]</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Cory1">[10]</xref>
###xml 616 620 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Adams1">[12]</xref>
###xml 888 892 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Hanahan2">[13]</xref>
###xml 894 898 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Christofori1">[14]</xref>
###xml 1823 1827 1811 1815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Naik1">[15]</xref>
###xml 2157 2161 2145 2149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Lopez1">[16]</xref>
###xml 2353 2357 2341 2345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Efrat1">[17]</xref>
###xml 2359 2363 2347 2351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Christofori2">[18]</xref>
###xml 2718 2722 2706 2710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Christofori2">[18]</xref>
###xml 2724 2728 2712 2716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Naik2">[19]</xref>
###xml 254 264 <span type="species:ncbi:6239">C. elegans</span>
###xml 755 760 <span type="species:ncbi:10090">mouse</span>
###xml 900 904 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1010 1013 <span type="species:ncbi:10116">rat</span>
###xml 1255 1259 <span type="species:ncbi:10090">mice</span>
The first direct genetic connection between modulation of apoptosis and tumor growth came from the discovery that expression of the Bcl-2 gene was dysregulated via chromosomal translocation in follicular lymphoma, and that this gene is homologous to the C. elegans regulator of cell death, ced-9 [6]-[9]. Bcl-2 proved to be the prototype of a family of structurally related apoptotic regulators, divided into two sub-groups that alternatively suppress or induce apoptosis [10]. The anti-apoptotic arm of the Bcl-2 family includes Bcl-2, Bcl-x (multiple anti-apoptotic splice variants), Bcl-w, A1, Mcl-1 and Boo [10]-[12]. Activation of apoptosis in response to oncogene-induced hyperproliferation has been described in a variety of genetically engineered mouse models of cancer, and in particular in two models of pancreatic neuroendocrine islet cell cancer. In one such model, RIP1-Tag2 [13], [14], SV40 T-antigens are constitutively expressed in the beta-cells of the endocrine pancreas under control of the rat insulin promoter, resulting in a multistage pathway to invasive carcinoma that is stochastic in nature and temporally protracted. At 2-3 weeks of age, the normal post-natal developmental proliferation of islet cells tapers off, and in adult mice there is a relatively slow turnover of beta-cells, with a low proliferation rate offset by a low apoptotic rate, which results in a very modest increase in beta-cell mass with age. In contrast, the beta-cells of RIP1-Tag2 islets begin hyperproliferating at 3-4 weeks of age along with a concomitant activation of apoptosis. An early study reported that apoptosis peaked at the angiogenic islet stage but was significantly down-modulated in tumors, suggesting that resistance to cell death was a critical step of tumor development from angiogenic islet precursors [15]. A more recent study of this model has shown that down-modulation is not always the case, in that late-stage tumors (including invasive carcinomas) in the current backcross generations typically have apoptotic rates similar to those of angiogenic islets, suggesting a more subtle phenomena at play in expansive tumor growth (ref [16]). Two well-defined suppressors of apoptosis have been identified in this model: functional inactivation of p53 via large T-antigen expression, and up-regulation of the survival factor IGF-II [17], [18]. Genetic studies involving crosses to an IGF-II null allele indicated that it largely functions as a survival factor in this model, in that absence of IGF-II evoked much increased (5x) apoptotic rates in hyper-proliferative lesions, and the small tumors arising had a less malignant cellular phenotype; notably, the proliferation rate remained unchanged [18], [19].
###end p 6
###begin p 7
###xml 149 150 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sub>L</sub></italic>
###xml 204 205 201 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 195 205 192 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Bcl-x<sub>L</sub></italic>
###xml 337 341 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Naik1">[15]</xref>
###xml 376 377 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 371 377 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sub>L</sub></italic>
###xml 512 515 509 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAM</sup>
###xml 595 599 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Pelengaris1">[20]</xref>
###xml 604 607 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAM</sup>
###xml 786 789 780 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAM</sup>
###xml 1020 1021 1008 1009 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1015 1021 1003 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sub>L</sub></italic>
###xml 1044 1045 1032 1033 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1035 1045 1023 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Bcl-x<sub>L</sub></italic>
###xml 1322 1323 1307 1308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1317 1323 1302 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sub>L</sub></italic>
###xml 173 176 <span type="species:ncbi:10116">rat</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
###xml 574 577 <span type="species:ncbi:10116">rat</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 1208 1213 <span type="species:ncbi:10090">mouse</span>
A demonstration that anti-apoptotic members of the Bcl-2 family can modulate cell-death in this model came from experimental over-expression of Bcl-xL in beta-cells via the rat insulin promoter (RIP-Bcl-xL), which resulted in suppressed apoptosis and an increase in tumor burden, along with a general "acceleration" of the tumor pathway [15]. More recently, the same RIP-Bcl-xL transgene has also been shown to suppress apoptosis in another mouse model of islet cell carcinoma, in which a myc fusion protein, mycTAM, was expressed in the beta-cells under the control of the rat insulin promoter [20]. MycTAM is only active in the presence of tamoxifen, allowing for inducible and reversible gene expression. Postnatal treatment of mice with tamoxifen results in a rapid induction of mycTAM expression concomitant with hyper-proliferation of the beta-cells. Interestingly, this hyper-proliferation was accompanied by massive beta-cell apoptosis that resulted in islet involution within 6-10 days. Over-expression of Bcl-xL via the same RIP-Bcl-xL transgene suppressed this apoptosis, resulting in an increase in beta-cell mass and a rapid progression to invasive carcinomas. Thus, in two different transgenic mouse models of islet cell carcinoma, elicited by two functionally distinct oncoproteins, over-expression of Bcl-xL suppresses apoptosis, resulting in accelerated tumor formation. The results indicate that the apoptosis observed in these tumor types is, at least in part, mediated by the mitochondrial death pathway. In this report, we explore the role that endogenous Bcl-x plays in modulating apoptosis and tumor growth in the RIP1-Tag2 model via targeted deletion of the gene in the oncogene-expressing beta-cells using the Cre/loxP system.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Bcl-x expression in RIP1-Tag2 islet cell carcinogenesis
###end title 9
###begin p 10
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Naik1">[15]</xref>
###xml 502 510 502 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g001">Figure 1</xref>
###xml 564 565 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 770 774 770 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</sub>
###xml 774 778 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Ban1">[21]</xref>
###xml 780 784 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Shiraiwa1">[22]</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
In situ hybridization with a pan-isoform probe to pancreatic tissue sections from RIP1-Tag2 mice previously suggested that Bcl-x mRNA was modestly up-regulated in tumors relative to precursor lesions [15]. To confirm that Bcl-x is appreciably expressed at the protein level during islet tumorigenesis, we went on to assess the levels of Bcl-x protein by Western blotting using lysates from normal islets and from the discrete stages of pancreatic islet tumorigenesis in RIP1-Tag2 mice. As indicated in Figure 1, a band migrating at 27 kDa consistent with the Bcl-xL isoform was detected at similar levels in normal islets and in the three neoplastic stages. In addition, a slightly faster migrating band, potentially corresponding to the alternative splice variant Bcl-xbeta[21], [22], was detected in the angiogenic islet and tumor stage but not normal islets or the hyperplastic islet stage. Thus the overall levels of Bcl-x protein are modestly elevated in the angiogenic islet and tumor stages.
###end p 10
###begin title 11
Bcl-x expression during RIP1-Tag2 tumor progression.
###end title 11
###begin p 12
###xml 260 261 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 387 391 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</sub>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
Protein extracts from pools of normal, non-transgenic islets (N), hyperplastic islets (H), angiogenic islets (A), and tumors (T) from RIP1-Tag2 mice were immunoblotted with antibodies to Bcl-x and beta-actin as loading control. The 27 kDa band represents Bcl-xL; the faster migrating band present in angiogenic islet and tumor extracts may represent the alternative splice variant, Bcl-xbeta.
###end p 12
###begin title 13
Generating a beta-cell specific gene knockout of bcl-x
###end title 13
###begin p 14
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 324 328 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Gannon1">[23]</xref>
###xml 330 334 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Postic1">[24]</xref>
###xml 359 364 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 371 376 365 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 366 376 360 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 562 566 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Gannon1">[23]</xref>
###xml 567 571 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Rucker1">[25]</xref>
###xml 592 599 586 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 606 611 600 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 601 611 595 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 769 776 760 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 783 788 774 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 778 788 769 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 798 803 789 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 793 803 784 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 977 982 968 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 964 982 955 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre:Bcl-x<sup>fl/fl</sup></italic>
###xml 988 991 979 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 1161 1170 1152 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g002">Figure 2A</xref>
###xml 1439 1446 1427 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1453 1458 1441 1446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1448 1458 1436 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1506 1511 1491 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1744 1751 1726 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1758 1763 1740 1745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1753 1763 1735 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1894 1903 1876 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g002">Figure 2B</xref>
###xml 1946 1953 1928 1935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1960 1965 1942 1947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1955 1965 1937 1947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 2087 2094 2069 2076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 2101 2106 2083 2088 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 2096 2106 2078 2088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
###xml 1009 1013 <span type="species:ncbi:10090">mice</span>
###xml 1459 1463 <span type="species:ncbi:10090">mice</span>
###xml 1764 1768 <span type="species:ncbi:10090">mice</span>
###xml 2107 2111 <span type="species:ncbi:10090">mice</span>
To assess the functional role of Bcl-x in RIP1-Tag2 tumorigenesis, we inactivated the Bcl-x gene in the beta-cells of the endocrine pancreas using the Cre/loxP system of homologous recombination. The RIP-Cre line employed expresses Cre in approximately 82% of the beta-cells, mediating efficient recombination at loxP sites [23], [24]. The "floxed" allele of Bcl-x, Bcl-xfl/fl, in which exons 1 and 2 are flanked by loxP sites, has been shown to be an efficient substrate for the Cre recombinase, producing a null allele following recombination in other tissues [23]-[25]. We first generated RIP-Cre, Bcl-xfl/fl mice (and various control genotypes) lacking the oncogene, and aged them out to >12 wks to assess possible effects on beta cell development and homeostasis. RIP-Cre; Bcl-xfl/fl and Bcl-xfl/fl mice were born in expected Mendelian ratios, and reached adulthood without early lethality or overt pathology. We examined H&E stained pancreatic sections from RIP-Cre:Bcl-xfl/fl, and Cre-negative control mice using light microscopy. No obvious difference in islet size, distribution, or number was observed in a double-blind examination of these sections (Figure 2A). The results imply that beta-cell development and islet morphogenesis were substantively normal in the absence of Bcl-x function, although subtle physiological effects cannot be excluded by this analysis. An alternative explanation for the lack of overt phenotype in RIP-Cre; Bcl-xfl/fl mice would be that the beta-cells with deleted Bcl-x died, and thus the normal islets observed were derived from non-recombined, "escaper" beta-cells that did not express the transgene-derived Cre. To assess this possibility, we isolated genomic DNA from pools of islets isolated from RIP-Cre; Bcl-xfl/fl mice and conducted PCR analysis with primers that would amplify and distinguish a recombined allele from a non-recombined allele (Figure 2B). Efficient recombination was detected in RIP-Cre; Bcl-xfl/fl islets. As expected, the recombined allele was not detected in controls lacking the RIP-Cre transgene (or in spleen from RIP-Cre; Bcl-xfl/fl mice, where Cre is not expressed).
###end p 14
###begin title 15
###xml 12 17 12 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre Bclx<sup>fl/fl</sup></italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
RIP-Cre Bclxfl/fl mice exhibit normal islet morphology and efficient Bcl-x recombination.
###end title 15
###begin p 16
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>+/+</sup></italic>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 96 112 96 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre;Bcl-x<sup>+/+</sup></italic>
###xml 131 137 131 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fll</sup>
###xml 114 137 114 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and RIP-Cre;Bcl-x<sup>fl/fll</sup></italic>
###xml 597 618 597 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
(A) H&E stained pancreatic sections from 12 week old mice of the following genotypes: Bcl-x+/+; RIP-Cre;Bcl-x+/+; and RIP-Cre;Bcl-xfl/fll. Multiple sections of each of the animals depicted in photomicrographs were examined. (B) Genomic DNA from pools of pancreatic islets was isolated from mice of distinct genotypes. PCR was carried out using a primer that binds upstream of the 5' loxP site and another primer that binds 3' to the downstream loxP site. The PCR fragment of the non-recombined allele and the recombined allele are 2.9 kb and 150 bp, respectively. Pancreatic islets were isolated (Materials and Methods) from 4-6 animals of each genotype and pooled.
###end p 16
###begin title 17
Assessing the functional role of Bcl-x in RIP1-Tag2 tumorigenesis
###end title 17
###begin p 18
###xml 150 155 150 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 145 155 145 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 350 353 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 362 366 362 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/+</sup>
###xml 345 366 345 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>+/+</sup> or Bcl-x<sup>fl/+</sup></italic>
###xml 515 520 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 581 590 581 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g003">Figure 3A</xref>
###xml 786 795 786 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g003">Figure 3B</xref>
###xml 976 985 976 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 987 994 987 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1001 1006 1001 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 996 1006 996 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1011 1020 1011 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1027 1032 1027 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1022 1032 1022 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1206 1215 1206 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g003">Figure 3C</xref>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
To investigate the role of Bcl-x in modulating apoptosis during RIP1-Tag2 tumorigenesis, we generated compound mice that were homozygous for the Bcl-xfl/fl allele and either carried both the RIP1-Tag2 and the RIP-Cre transgenes, or just the RIP1-Tag2 transgene. Additional controls included mice that carried the RIP1-Tag2 transgene, and either Bcl-x+/+ or Bcl-xfl/+ alleles. We aged out cohorts of these mice to 13 weeks of age, and quantified both tumor burden (volume) and tumor number. The targeted knockout of Bcl-x did not result in a significant difference in tumor burden (Figure 3A). This essentially "wild-type" tumor burden in the knockout animals was accompanied by an approximately 40% decrease in tumor number; however, this effect did not reach statistical significance (Figure 3B). To determine if this lack of overt phenotypic effect on tumor growth was also reflected in the apoptotic rate, we performed TUNEL assays on formalin-fixed paraffin sections from RIP1-Tag2; RIP-Cre; Bcl-xfl/fl and RIP1-Tag2; Bcl-xfl/fl animals. As suggested by the tumor burden and tumor number data, there was no significant difference in the apoptotic rate in tumors from "knockout" versus control animals (Figure 3C).
###end p 18
###begin title 19
RIP1-Tag2 tumorigenesis is not dependent on Bcl-x function.
###end title 19
###begin p 20
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 601 602 597 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
(A and B) Comparison of tumor volume and number. Macroscopically visible tumors from 13 week old animals were excised, attached exocrine tissue removed and measured with ruler. Tumor volume was calculated using the formula V = (x * y2)x0.52. Data represent Mean+/-SEM; +/+ and FL/+: n = 7; FL/FL: n = 24; RIP-Cre;Fl/Fl: n = 22. Statistical significance was determined by non-parametric T-test (Mann-Whitney). P = 0.98 (D) Apoptotic rate. Apoptotic cells were quantified via TUNEL labeling of pancreatic sections from 13 week old animals. Data represent Mean+/-SEM (n = 5 mice/group). The percent TUNEL+ cells was calculated from sections of 16-17 individual tumors/group. Statistical significance determined by non-parametric T-test (Mann-Whitney). P = 0.98.
###end p 20
###begin p 21
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 70 79 70 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 95 100 95 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 90 100 90 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 225 226 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 342 351 342 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g004">Figure 4A</xref>
###xml 540 545 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 646 649 631 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 641 649 626 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>+/+</sup></italic>
###xml 860 864 842 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Inoue1">[26]</xref>
###xml 1085 1090 1067 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1183 1192 1165 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1194 1201 1176 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1208 1213 1190 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1203 1213 1185 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1228 1237 1210 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1244 1249 1226 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1239 1249 1221 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1260 1270 1242 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g004">Figures 4B</xref>
###xml 1275 1277 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004455.s001">S1</xref>
###xml 1317 1322 1299 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1349 1358 1331 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1360 1367 1342 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1374 1379 1356 1361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1369 1379 1351 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1399 1408 1381 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1415 1420 1397 1402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1410 1420 1392 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1447 1452 1429 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1561 1566 1540 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1736 1745 1712 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1747 1754 1723 1730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1761 1766 1737 1742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1756 1766 1732 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1911 1916 1887 1892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1929 1938 1905 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g004">Figure 4C</xref>
###xml 2025 2030 2001 2006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 2117 2122 2093 2098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 2212 2217 2173 2178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 2275 2280 2236 2241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 2373 2378 2331 2336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 2433 2438 2391 2396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 2675 2680 2633 2638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 2754 2759 2709 2714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 2819 2824 2774 2779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 2991 3008 2946 2963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2;RIP-Cre</italic>
###xml 3015 3020 2970 2975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 3010 3020 2965 2975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 3125 3130 3080 3085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 3229 3238 3184 3193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g004">Figure 4D</xref>
###xml 3281 3286 3236 3241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 3331 3348 3286 3303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2;RIP-Cre</italic>
###xml 3355 3360 3310 3315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 3350 3360 3305 3315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 3482 3490 3437 3445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g001">Figure 1</xref>
###xml 3518 3523 3473 3478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
To verify that Bcl-x was efficiently deleted in the tumors arising in RIP1-Tag2; RIP-Cre; Bcl-xfl/fl mice, we monitored recombination using a PCR-based assay on genomic DNA from 12 randomly picked tumors (range 5.2 mm3-229 mm3): 10/12 tumors exhibited complete recombination, 1/12 showed partial recombination, and 1/12 had no recombination (Figure 4A and data not shown). Given the fact that the Cre transgene is not efficiently expressed in 10-20% of the beta-cells, and noting that the ratio of tumors with recombined vs. non-recombined Bcl-x alleles was also approximately10%, we conclude that there was no selective growth advantage of Bcl-x+/+ cells that manifested itself in the clonal outgrowth of beta-cells harboring non-recombined alleles, in contrast to the situation with other genes that have critical roles in RIP1-Tag2 tumorigenesis (e.g. VEGF [26]). Notably, some of the largest tumors exhibited complete recombination, again supporting the notion that loss of Bcl-x function was not impairing tumor growth. As another measure of recombination efficiency, we assessed Bcl-x expression by quantitative RT-PCR (Taqman) on first strand cDNA derived from 10 independent RIP1-Tag2; RIP-Cre; Bcl-xfl/fl tumors and 10 RIP1-Tag2; Bcl-xfl/fl controls (Figures 4B and S1). There was a significant reduction in Bcl-x expression in 9/10 of the RIP1-Tag2; RIP-Cre; Bcl-xfl/fl tumors compared to RIP1-Tag2; Bcl-xfl/fl controls, indicating that Bcl-x was deleted in the majority of beta-cells in these tumors. However, one tumor expressed wild-type levels of Bcl-x, suggesting that it arose from a beta-cell that did not express Cre, and thus harbored a non-recombined allele. This prediction was confirmed by screening all 10 of the RIP1-Tag2; RIP-Cre; Bcl-xfl/fl tumors for Cre expression, and as predicted this exceptional tumor did not express Cre, in contrast to the 9 tumors that exhibited much reduced Bcl-x expression (Figure 4C). Excluding this Cre-negative, Bcl-x-positive "escaper" tumor from analysis, the mean Bcl-x expression in "KO" tumors was 9.5-fold lower than that of controls. Thus, deletion of Bcl-x in the beta-cell compartment of these tumors resulted in a approximately90% reduction of Bcl-x expression, thereby confirming that the preponderance of Bcl-x expression in RIP1-Tag2 tumors is beta-cell in origin and that Cre was efficiently deleting Bcl-x without apparent phenotypic consequence. The residual Bcl-x expression likely originates from the stromal component of the lesions (principally vascular and immune cell types), although we cannot formally rule out the possibility that these tumors are oligo-clonal, and that some of the residual Bcl-x mRNA is derived from relatively rare beta-cells harboring non-recombined Bcl-x alleles. To determine whether the significant reduction of Bcl-x mRNA observed in bcl-x "KO" tumors resulted in a commensurate reduction in Bcl-x protein levels, we carried out a Western blot analysis on lysates from 5 independent RIP1-Tag2;RIP-Cre; Bcl-xfl/fl tumors. Consistent with the PCR-based analysis of recombination and the quantitative RT-PCR analysis of Bcl-x mRNA levels, Bcl-x protein levels were significantly reduced compared to wild-type (w.t.) tumors (Figure 4D), indicating Cre-mediated deletion of the Bcl-x locus in the vast majority of beta cells of RIP1-Tag2;RIP-Cre; Bcl-xfl/fl tumors. In addition, this result confirms that the immunoreactive bands detected in normal islets and RIP1-Tag2 lesions (Figure 1) were in fact derived from Bcl-x. Together, the data support the conclusion that Bcl-x does not have a central role in modulating tumor apoptosis in this pathway, and that its function is either non-essential, redundant, and/or readily compensated for by other genes, such as other anti-apoptotic members of Bcl-2 family.
###end p 21
###begin title 22
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 47 56 47 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 72 77 72 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 67 77 67 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
Bcl-x expression is ablated in the majority of RIP1-Tag2; RIP-Cre; Bcl-xfl/fl tumors.
###end title 22
###begin p 23
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 40 49 40 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 65 70 65 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 60 70 60 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 132 141 132 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 143 150 143 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 157 162 157 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 152 162 152 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 167 176 167 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/f</sup>
###xml 178 187 178 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/f</sup></italic>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</italic>
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>l</italic></sup>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bclx</italic>
###xml 555 557 555 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 628 637 628 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 639 646 639 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 653 658 653 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 648 658 648 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 663 672 663 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 679 684 679 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 674 684 674 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 895 904 895 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 906 913 906 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 920 925 920 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 915 925 915 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 945 950 945 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1011 1013 1011 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 1084 1093 1084 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1095 1102 1095 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1109 1114 1109 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1104 1114 1104 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1119 1128 1119 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1135 1140 1135 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1130 1140 1130 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1380 1385 1380 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1435 1443 1435 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g001">Figure 1</xref>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
(A) Efficient recombination of Bcl-x in RIP1-Tag2; RIP-Cre; Bcl-xfl/fl tumors. Genomic DNA was isolated from individual tumors from RIP1-Tag2; RIP-Cre; Bcl-xfl/fl and RIP1-Tag2; Bcl-xfl/fl mice. PCR was carried out using a primer that binds upstream of the 5' loxP site and another primer that binds 3' to the downstream loxP site. The PCR fragment of the non-recombined allele and the recombined allele are 2.9 kb and 150 bp, respectively. (B) Bcl-x expression is significantly reduced in Bclx-KO tumors. Quantitative RT-PCR (Taqman) was carried out on 1st strand cDNA synthesized from RNA isolated from individual tumors from RIP1-Tag2; RIP-Cre; Bcl-xfl/fl and RIP1-Tag2; Bcl-xfl/fl. A spanning probe that detected all major anti-apoptotic splice variants was used. Gene expression was normalized to and plotted as a function of GAPDH expression. (D) The RIP-Cre transgene is not expressed in RIP1-Tag2; RIP-Cre; Bcl-xfl/fl tumors that retain Bcl-x expression. Cre mRNA expression was monitored by RT-PCR on 1st strand cDNA synthesized from RNA isolated from individual tumors from RIP1-Tag2; RIP-Cre; Bcl-xfl/fl and RIP1-Tag2; Bcl-xfl/fl mice. Following 27 cycles of PCR, the cDNA was fractionated on agarose gels and visualized by ethidium bromide staining. The PCR product is 520 bp. *non-recombined, Cre-negative tumor. (D) Bcl-x protein levels are significantly reduced in Bcl-x-KO tumors, as revealed by Western blotting as in Figure 1. beta-actin is used as a loading control.
###end p 23
###begin title 24
Expression profiling other Bcl-2 family members in islet tumorigenesis
###end title 24
###begin p 25
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-w</italic>
###xml 236 238 236 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcl-1</italic>
###xml 250 253 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Boo</italic>
###xml 314 316 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 469 478 469 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g005">Figures 5</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004455.s002">S2</xref>
###xml 532 535 532 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Boo</italic>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Song1">[27]</xref>
###xml 762 767 762 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-w</italic>
###xml 806 811 806 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1018 1027 1018 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004455.s003">Figure S3</xref>
###xml 1219 1224 1219 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1306 1315 1306 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1317 1324 1317 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1331 1336 1331 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1326 1336 1326 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1344 1353 1344 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1360 1365 1360 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1355 1365 1355 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1382 1387 1382 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1418 1427 1418 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g004">Figure 4B</xref>
###xml 1523 1532 1523 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g006">Figures 6</xref>
###xml 1537 1539 1537 1539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004455.s004">S4</xref>
###xml 1806 1811 1806 1811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 367 382 <span type="species:ncbi:10090">transgenic mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
Next, we sought to determine whether the 5 other known anti-apoptotic members of the Bcl-2 family might be expressed during RIP1-Tag2 tumorigenesis, thereby potentially compensating for the absence of Bcl-x. We quantified Bcl-2, Bcl-w, A1, Mcl-1 and Boo mRNA levels using quantitative RT-PCR analysis (Taqman) on 1st strand cDNA from normal islets (isolated from non-transgenic mice), hyperplastic islets, angiogenic islets, and tumors from RIP1-Tag2 mice. As shown in Figures 5 and S2, four of the genes were expressed; the fifth, Boo, was not detected in some of samples and was highly variable in replicate assays, consistent with its expression being largely restricted to the male and female reproductive organs [27]. Among the four expressed members, only Bcl-w was expressed at levels comparable to Bcl-x. Expression levels are presented relative to the control gene, GAPDH, which exhibited the least variable expression compared to L19 and Gus between normal islets and the different neoplastic islet lesions (Figure S3). To determine if one or more of the anti-apoptotic Bcl-2 family members was transcriptionaly up-regulated in the absence of Bcl-x and therefore potentially functionally compensating for the Bcl-x "knockout", we performed quantitative RT-PCR analysis on the same 10 independent RIP1-Tag2; RIP-Cre; Bcl-xfl/fl and 10 RIP1-Tag2; Bcl-xfl/fl tumors in which Bcl-x expression was quantified (in Figure 4B). There proved to be no significant difference in the mRNA expression levels of these 5 genes (Figures 6 and S4). Additionally, Taqman analysis of the same tumor cDNAs for up-regulation of members of the IAP class of anti-apoptotic proteins (CIAP1, CIAP2, Survivin, XIAP, and BRUCE) similarly failed to reveal any significant transcriptional up-regulation of these genes in the Bcl-x-KO tumors (data not shown).
###end p 25
###begin title 26
Expression of anti-apoptotic Bcl-2 family members in the stages of islet tumor development.
###end title 26
###begin p 27
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-w</italic>
###xml 78 80 78 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1</italic>
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcl-1</italic>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Boo</italic>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
The mRNA levels of the pro-survival Bcl-2 family members Bcl-x, Bcl-2, Bcl-w, A1, Mcl-1 and Boo were assessed using quantitative RT-PCR (Taqman) on first strand cDNA synthesized from total RNA pools (4-6 animals per pool) of normal, non-transgenic islets, and of hyperplastic islets, angiogenic islets, and tumors from RIP1-Tag2 mice. Gene expression was normalized to and plotted as a percentage of GAPDH expression.
###end p 27
###begin title 28
Loss of Bcl-x does not elicit transcriptional up-regulation of other anti-apoptotic Bcl-2 family members.
###end title 28
###begin p 29
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-w</italic>
###xml 40 42 40 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1</italic>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcl-1</italic>
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Boo</italic>
###xml 192 201 192 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 203 210 203 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 217 222 217 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 212 222 212 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 351 360 351 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 367 372 367 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 362 372 362 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
The mRNA levels of Bcl-x, Bcl-2, Bcl-w, A1, Mcl-1 and Boo were assessed using quantitative RT-PCR (Taqman) on first strand cDNA synthesized from total RNA isolated from individual tumors from RIP1-Tag2; RIP-Cre; Bcl-xfl/fl (n = 9 tumors from 5 mice; 1 tumor found to not express Cre and exhibit wild-type levels of Bcl-x excluded from these data) and RIP1-Tag2; Bcl-xfl/fl mice (n = 10 tumors from 5 individual mice). Relative gene expression was normalized to and presented as a percentage of GAPDH expression. Data represents mean+/-SEM. Statistical significance determined by non-parametric T-test (Mann-Whitney). P<0.05 considered significant.
###end p 29
###begin title 30
Role of Bcl-x in modulating invasion in RIP1-Tag2 tumorignesis
###end title 30
###begin p 31
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Choi1">[28]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Wick1">[31]</xref>
###xml 246 247 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Weiler1">[29]</xref>
###xml 365 366 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Du1">[32]</xref>
###xml 705 714 705 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 721 726 721 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 716 726 716 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 731 740 731 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 742 749 742 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 756 761 756 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 751 761 751 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 932 936 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Lopez1">[16]</xref>
###xml 1037 1046 1037 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1048 1055 1048 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 1062 1067 1062 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1057 1067 1057 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1085 1094 1085 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1101 1106 1101 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1096 1106 1096 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1138 1147 1138 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g007">Figures 7</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004455.s005">S5</xref>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 1068 1072 <span type="species:ncbi:10090">mice</span>
###xml 1107 1111 <span type="species:ncbi:10090">mice</span>
In addition to modulating apoptosis in tumor cells, there have been reports that Bcl-2 family members can additionally promote carcinogenesis via effects on tumor cell invasion [28]-[31]. In one report, a dissociation between the ability of Bcl-xL to modulate apoptosis and invasiveness of human glioma cells was observed [29]. More recently, up-regulation of Bcl-xL by somatic gene transfer during RIP1-Tag2 tumorigenesis was reported to increase invasiveness, without reducing apoptosis [32]. Motivated by these results, and by the evident lack of effect of loss of Bcl-x on overall RIP1-Tag2 tumor cell apoptosis and tumor burden, a potential role for Bcl-x in tumor invasion was assessed. Tumors from RIP1-Tag2; Bcl-xfl/fl and RIP1-Tag2; RIP-Cre; Bcl-xfl/fl mice were scored as non-invasive, encapsulated tumors (IT) or invasive carcinomas (IC1-microinvasive; IC2-highly invasive) according to the criteria of Lopez and Hanahan [16]. Interestingly, there was a significantly higher proportion of encapsulated, non-invasive tumors in RIP1-Tag2; RIP-Cre; Bcl-xfl/fl mice compared to RIP1-Tag2; Bcl-xfl/fl mice (22.8% vs. 4.3%; p<0.02) (Figures 7 and S5).
###end p 31
###begin title 32
Loss of Bcl-x expression results in an altered proportion of adenomas and carcinomas.
###end title 32
###begin p 33
###xml 42 51 42 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 58 63 58 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 53 63 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Cre</italic>
###xml 121 126 121 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 116 126 116 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
Tumors in H&E-stained sections from 13 wk RIP1-Tag2; Bcl-xfl/fl (n = 46 tumors from 5 mice) and RIP1-Tag2; RIP-Cre; Bcl-xfl/fl mice (n = 35 tumors from 5 mice) were scored as either non-invasive islet tumors/adenomas (IT) or invasive carcinomas (either IC1 or IC2) and the proportion of tumors in each class was calculated. Distribution of tumors types was compared between the two groups using Fisher's exact test. p = 0.017.
###end p 33
###begin p 34
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 225 234 213 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 241 246 229 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 236 246 224 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 484 493 472 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g008">Figure 8A</xref>
###xml 535 540 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 730 735 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 1171 1180 1153 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g008">Figure 8B</xref>
###xml 1410 1421 1392 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g008">Figure 8C,D</xref>
###xml 1519 1523 1498 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Du1">[32]</xref>
###xml 1898 1902 1877 1881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Graham1">[33]</xref>
###xml 1903 1907 1882 1886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Casanovas1">[36]</xref>
###xml 2032 2033 2011 2012 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2143 2147 2122 2126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Wang1">[37]</xref>
###xml 2149 2153 2128 2132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Chandel1">[38]</xref>
###xml 2209 2218 2188 2197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g008">Figure 8B</xref>
###xml 2375 2386 2354 2365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g008">Figure 8C,D</xref>
###xml 2501 2502 2480 2481 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2554 2563 2530 2539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g008">Figure 8C</xref>
###xml 2804 2813 2780 2789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004455-g008">Figure 8D</xref>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
To substantiate the effect of loss of Bcl-x on invasion, cancer cells with wild-type or deleted Bcl-x (betaTC-Bcl-x-wt or betaTC-Bcl-x-knockout [KO]) were generated by deriving beta-tumor cell lines ("betaTC") from tumors of RIP1-Tag2; Bcl-xfl/fl mice, and infecting the cells with adenoviruses that do or do not express Cre (Ad-Cre-GFP or Ad-GFP). Two weeks post-infection with Ad-Cre-GFP, the levels of Bcl-x protein within the cell population were reduced by approximately 75-80% (Figure 8A), likely reflecting recombination of the Bcl-x gene in the majority of cells; serum-starved cells +/-Cre were seeded into the upper chambers of porous transwell inserts either uncoated or Matrigel-coated to assess the effect of loss of Bcl-x expression on migration and invasion, respectively. To account for any potential differences in cell growth between betaTC-Bcl-x-wt or betaTC-Bcl-x-KO cells over the time course of the migration/invasion assays, equal numbers of cells were plated in triplicate, and total cell numbers determined after a 48-hour incubation. During this time period, there was no apparent difference in cell growth between wild-type and Bcl-x-KO cells (Figure 8B). This was consistent with the lack of effect of loss of Bcl-x function on tumor growth and apoptosis in vivo. In addition, there was no significant difference in the number of migrating or invading cells along a serum gradient (Figure 8C,D). However, the betaTC cells were poorly invasive in these ex vivo assays, as reported previously [32], in contrast to the common appearance of invasive cancer cells during tumor progression. We wondered, therefore, whether the typical cell culture conditions might not properly model the invasion-inducing microenvironment in vivo. Notably, various reports, including previous studies in the RIP1-Tag2 model, have demonstrated a role for hypoxia in stimulating tumor invasion [33]-[36]. We therefore repeated the migration/invasion assays in conditions mimicking hypoxia, by incorporating cobalt chloride (CoCl2), which has been shown to induce biochemical responses similar to those observed under low oxygen conditions [37], [38]. In this condition, overall cell survival was reduced (Figure 8B) though the wild-type cells evidenced a 2-fold increase in the number of migrating cells (p = 0.006), and a 1.5-fold increase in invading cells (p = 0.07) (Figure 8C,D) relative to the total number of surviving cells. A similar increase in migration was observed in response to CoCl2 treatment of the betaTC-Bcl-x-KO cells (p = 0.02) (Figure 8C); in contrast, these cells did not exhibit increased invasion under these pseudo-hypoxic conditions, and compared to the wild-type cells exhibited a modest yet significant decrease (45%; p = 0.005) in the relative number of invading cells (Figure 8D). These data, consistent with the in vivo analysis, suggest that while expression of multiple Bcl-2 family members may render Bcl-x functionally redundant in terms of effects on tumor cell apoptosis, Bcl-x may exhibit non-redundant and distinct functions in regard to tumor invasiveness.
###end p 34
###begin title 35
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Effect of Bcl-x gene knockout on in vitro migration and invasion of tumor cells.
###end title 35
###begin p 36
###xml 12 17 9 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 7 17 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 303 308 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 308 313 302 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 394 395 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 408 413 399 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 403 413 394 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 473 474 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 857 858 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1189 1190 1175 1176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
betaTC-Bcl-xfl/fl tumor cells were infected with adenovirus expressing Cre or control GFP and plated in triplicate in the presence or absence of cobalt chloride to assess the effect of reduced Bcl-x expression on cell migration and invasion. (A) Western blot of Bcl-x and actin protein levels in betaTC-Bcl-xfl/fl cells treated +/-Cre at time of migration/invasion assays. (B) Cell growth. 2x105 betaTC-Bcl-xfl/fl cells +/-cre were plated in the presence or absence of CoCl2 and cells were counted after 48 hours. (C and D) Cell migration and invasion assays. Cells were plated in control trans-well inserts (C) or Matrigel-coated inserts (D). For the migration assay, results are plotted as the mean number of migrating cells/10x field (8 fields/membrane counted), while for the invasion assays the total number of invading cells/membrane are plotted. CoCl2 treatment resulted in a significant decrease in invasion of betaTC-Bcl-x-KO cells compared to wild-type cells (P = 0.005). Results shown represent the mean+/-SEM of results from three independent experiments performed in triplicate and are corrected for changes in total cell number (from B) compared to control cells (-Cre, -CoCl2).
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-w</italic>
###xml 459 461 459 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1</italic>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcl-1</italic>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
In this study, we sought to determine whether genetic deletion of one prominent anti-apoptotic member of the Bcl-2 family, Bcl-x, would impact tumorigenesis. We demonstrate that Bcl-x is non-essential for RIP1-Tag2 tumorigenesis, and that cells harboring null alleles of Bcl-x do not have an inherent survival disadvantage to cells expressing wild type Bcl-x. In addition, we demonstrate that 4 of the other anti-apoptotic Bcl-2 family members, Bcl-2, Bcl-w, A1 and Mcl-1 are reproducibly expressed in normal, non-transgenic islets and throughout multistage tumorigenesis in RIP1-Tag2 mice. Importantly, in tumors in which Bcl-x is deleted, mRNA expression of these genes remains unchanged, suggesting that Bcl-x in this tumor pathway is either non-essential, or functionally redundant, and thus readily substituted without overt transcriptional up-regulation of other members of this gene class. Based on the quantitative RT-PCR experiments presented in this study, a potential source of functional redundancy is Bcl-w, which appears to be expressed at significantly higher levels than Bcl-2, A1, Mcl-1 and Boo in both normal islets and lesional stages of the RIP1-Tag2 tumor pathway.
###end p 38
###begin p 39
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Kelly1">[39]</xref>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Strasser1">[40]</xref>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 487 488 487 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 482 488 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bcl-x<sub>L</sub></italic>
###xml 505 506 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 500 506 500 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sub>L</sub></italic>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Naik1">[15]</xref>
###xml 912 913 912 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 907 913 907 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bcl-x<sub>L</sub></italic>
###xml 932 935 932 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 964 968 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Pelengaris1">[20]</xref>
###xml 1000 1001 1000 1001 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 995 1001 995 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bcl-x<sub>L</sub></italic>
###xml 152 167 <span type="species:ncbi:10090">transgenic mice</span>
###xml 649 664 <span type="species:ncbi:10090">transgenic mice</span>
Our results are consistent with a recent study demonstrating that Bcl-2 is not strictly required for the development of myc induced lymphomas in Eu-myc transgenic mice [39]. Whereas previous studies had shown that myc plus over-expression of Bcl-2 synergized to accelerate lymphomagenesis in the Eu-myc model [40], the genetic ablation of Bcl-2 had no impact on the cancer phenotype. Similarly, in contrast to the loss of function studies presented above, forced over-expression of bcl-xL via a RIP7-Bcl-xL transgene has a profound effect on RIP1-Tag2 tumorigenesis, in that tumor progression is accelerated and tumor burden increased in the double transgenic mice [15]. This augmentation of tumorigenesis is accompanied by a significant decrease in the apoptotic rate. Similar results have been obtained in a model of islet cell tumorigenesis driven by an inducible c-myc oncogene, wherein upregulation of bcl-xL is obligatory for myc-induced islet tumorigenesis [20]. These data indicate that bcl-xL is a potent anti-apoptotic gene and tumor progression factor when up-regulated/over-expressed during lymphoid and pancreatic islet tumorigenesis, but that its anti-apoptotic functions are in some circumstances non-essential, likely due to the redundant functions of the other expressed Bcl-2 family members.
###end p 39
###begin p 40
###xml 288 292 <span type="species:ncbi:10090">mice</span>
Despite the evident redundancy of endogenous levels of Bcl-x in impacting apoptosis and tumor growth, a potentially distinct role of Bcl-x in influencing tumor invasion was revealed by the observation of an increased proportion of non-invasive adenomas compared to invasive carcinomas in mice lacking Bcl-x expression in the oncogene-expressing islet beta-cells. This histopathological implication is supported by experiments with islet tumor cell lines lacking Bcl-x expression. The Bcl-x-null cells exhibited a decreased capability to invade under conditions mimicking hypoxia; in contrast, when the same cells were assayed in normal conditions, their invasiveness was comparable to Bcl-x proficient cancer cells. This result suggests that while endogenous Bcl-x expression may be redundant under normal conditions, it can play a distinct role in stressed conditions (e.g. hypoxia, nutrient deprivation, chemotherapy).
###end p 40
###begin p 41
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Du1">[32]</xref>
###xml 355 356 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 491 492 491 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Naik1">[15]</xref>
###xml 664 665 664 665 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 728 729 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
Our findings implicating Bcl-x in invasion are notable in light of a recent study by Du et al., who reported a significant increase in the incidence of invasive carcinomas in RIP1-Tag2 mice engineered to focally over-express Bcl-xL via retrovirus-mediated somatic gene transfer into neoplastic lesions [32]. Interestingly, this mode of up-regulating Bcl-xL did not affect the incidence of apoptotic cells in the tumors, in contradistinction to the aforementioned study in which the RIP-Bcl-xL transgene produced a decreased apoptotic index [15]; such phenotypic differences may be explained by differences in the uniformity, timing or levels of expression of Bcl-xL (the effect of the transgene-mediated over-expression of Bcl-xL on tumor invasion was not assessed in this earlier study). Our current investigation now provides additional, complimentary data to that of Du et al in regard to this emergent function for Bcl-x, by demonstrating that endogenous Bcl-x, in the absence of overt over-expression, can influence tumor invasion.
###end p 41
###begin p 42
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Oltersdorf1">[41]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Konopleva1">[42]</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-vanDelft1">[43]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Chen1">[44]</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Lin1">[45]</xref>
###xml 949 953 <span type="species:ncbi:10090">mice</span>
Therapeutics that engage programmed cell death in tumor cells have promise for the treatment of cancer. Indeed compounds that broadly fall into this class have entered clinical development. ABT-737, a BH3 mimetic, is one example [41]. Recently, it has been reported that ABT-737 is not cytotoxic to all tumors cells, and that "chemoresistance" to ABT-737 is dependent on appreciable levels of Mcl-1 expression, the one Bcl-2 family member it does not effectively inhibit [42], [43]. Indeed, suppression of Mcl-1 protein levels by shRNA knockdown or indirect pharmacological downregulation sensitizes resistant tumor cells to ABT-737 mediated cell death [44], [45]. Collectively, the data suggest that activity among the pro-survival Bcl-2 family members is, in certain settings, functionally redundant, and that tumor cells utilize multiple Bcl-2 family members for survival and proliferation. The prediction follows that treatment of the RIP1-Tag2 mice with pan-Bcl inhibitors will disrupt tumor growth if indeed, (as expected) these genes cooperate in modulating the propensity for apoptosis as an intrinsic barrier to tumorigenesis. It will be of additional interest to ascertain whether such Bcl inhibitors can also restrict tumor invasion and malignancy, endpoints that could be of relevance in the clinical setting.
###end p 42
###begin title 43
Materials and Methods
###end title 43
###begin title 44
Real-time Q-PCR Analysis
###end title 44
###begin p 45
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Elson1">[46]</xref>
###xml 1055 1059 1055 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Elson1">[46]</xref>
###xml 1840 1849 1840 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004455.s003">Figure S3</xref>
Quantitative PCR was performed essentially as in Elson et al.[46] In brief, RNA was extracted using Qiagen RNase Easy as per manufacturer's instructions. RNA concentration was determined by spectrophotometer (NanoDrop, Rockland, DE). RNA quality was confirmed using a Bioanalyser (Agilent Technologies, Palo Alto, CA). Total RNA was incubated with DNase (DNA-free, Ambion, Austin, TX) to remove contaminating DNA. The DNase was inactivated and removed according to the manufacturer's specifications. 'No Reverse transcriptase' controls were performed on all samples to confirm that genomic DNA was not present. RNA was reverse transcribed into cDNA with iScript (Bio-Rad, Hercules CA), 300 ng in a 20 ul volume according to manufacturer's specifications. Quantitative-PCR analysis was performed on an AB Prism 7900 or 7700 sequence detection system (Applied Biosystems, Foster City, CA). Quantitative detection of specific nucleotide sequences was based on the fluorogenic 5' nuclease assay, and relative expression was calculated as previously described [46]. Assays were designed (using Primer Express software v1.5, Applied Biosystems) with 6-FAM fluorophore on the 5' end and the quencher BHQ1 on the 3' end and reactions were optimized to have >90% efficiency [or purchased as Assays-on-Demand from Applied Biosystems(AB)]. Primer and probe concentrations of 500 nM and 200 nM, were used respectively. The cDNA equivalent to 3-5 ng of RNA was measured in triplicate by real time PCR using QPCR master mix with final concentrations 5.5 mM MgCl2, 200 uM dNTPs and 0.5units Hotstart Amplitaq Gold (AB) in 20 ul volume 384 well plate or 50 uL volume for 96 well plates. For normalization, cDNA equivalent to 3-5 ng input RNA was measured for GAPDH, L19 and Gus. GAPDH expression was the least variable under these experimental conditions (Figure S3).
###end p 45
###begin p 46
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-w</italic>
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcl-1</italic>
###xml 231 233 231 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1</italic>
###xml 254 257 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Boo</italic>
For the detection of transcriptional target messages, the following primer and probe sets were used: pan-Bcl-x: ABI Assay on Demand (AOD) Mm00437783_m1; Bcl-w: AOD mM00432054_m1; Bcl-2: AOD Mm00477631_m1; Mcl-1: AOD Mm00725832_s1; A1: AOD Mm00833201_s1; Boo: AOD; Mm00478988_m1.
###end p 46
###begin title 47
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice breeding
###end title 47
###begin p 48
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Hanahan2">[13]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Gannon1">[23]</xref>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x</italic>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Rucker1">[25]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Wagner1">[47]</xref>
###xml 556 561 556 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/wt</sup>
###xml 551 561 551 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/wt</sup></italic>
###xml 616 621 616 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 611 621 611 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 640 648 640 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag2</italic>
###xml 650 658 650 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP2-Cre</italic>
###xml 664 669 664 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 660 669 660 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bclx<sup>fl/fl</sup></italic>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 128 143 <span type="species:ncbi:10090">transgenic mice</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
The generation of RIP1-Tag2 mice as a model of pancreatic islet cell carcinogenesis has been previously reported [13]. RIP2-Cre transgenic mice, kindly provided by Mark Magnuson (Vanderbilt University Medical Center, Nashville, TN) [23], were previously backcrossed into the C57-Bl/6J background for more than 15 generations. Bcl-x-floxed allele animals (mixed C57BL/6-129SvEv background) were previously described [25], [47]. They were backcrossed into the C57-Bl/6J background for 5 generations, then crossed with the RIP-Tag2 and the RIP2-Cre in a Bcl-xfl/wt heterozygous background and then intercrossed to Bcl-xfl/fl animals to obtain RIP-Tag2; RIP2-Cre; Bclxfl/fl animals. All experiments involving mice were approved by the University of California, San Francisco (UCSF) institutional review board.
###end p 48
###begin title 49
Tissue preparation and immunohistochemistry
###end title 49
###begin p 50
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Parangi1">[48]</xref>
###xml 917 921 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Lopez1">[16]</xref>
###xml 993 997 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Lopez1">[16]</xref>
###xml 999 1003 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Inoue1">[26]</xref>
###xml 1540 1544 1529 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Lopez1">[16]</xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 1105 1109 <span type="species:ncbi:10090">mice</span>
###xml 1333 1337 <span type="species:ncbi:10090">mice</span>
Normal (from non-transgenic C57Bl/6 mice), hyperplastic islets (from 4-6 wk RIP1-Tag2 mice; not red), and angiogenic islets (from 8-10 wk RIP1-Tag2 mice; red, with evident hemorrhages) were isolated as previously described [48]. Tumors were carefully microdissected away from the surrounding exocrine pancreas tissue of freshly excised pancreata (from 12-13 wk RIP1-Tag2 mice). For protein analysis, tissue was disrupted in RIPA buffer containing a protease inhibitor cocktail (Roche); western blotting was performed using antibodies to Bcl-x (Pharmingen) and beta-actin (Sigma) for a loading control. For immunohistochemical analysis, mice were anesthetized with tribromoethanol (Sigma) and heart-perfused with PBS and then 10% zinc-buffered formalin (Medical Chemical Corp.). Pancreata were removed and post-fixed in 10% zinc-buffered formalin overnight and processed for paraffin embedding as previously described [16]. TUNEL staining and H&E grading were performed as previously described [16], [26]. TUNEL quantification was performed on tumor-containing sections (5 microm paraffin) from at least 5 mice per group. Statistical analysis was performed using the non-parametric t-test (Mann-Whitney) and p values of less than 0.05 were considered statistically significant. For tumor grading, paraffin blocks from pancreases of 5 mice/group were sectioned and 5 slides 50 microm apart were stained by H&E. Tumors were blindly graded as either encapsulated, non-invasive tumors (IT) or invasive carcinoma type 1 or 2 (IC1,2) as described [16]. Differences in the proportion of IT and IC tumors in the two different genotypes were assessed by Fisher's exact test and a p value of less than 0.05 was considered statistically significant.
###end p 50
###begin title 51
Determination of tumor burden
###end title 51
###begin p 52
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004455-Bergers1">[49]</xref>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 297 302 <span type="species:ncbi:10090">mouse</span>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
Quantification of tumor burden was determined as previously described [49]. Briefly, tumors were microdissected and tumor dimensions were measured with a ruler, and tumor volume was calculated using the formula [volume = width2xlengthx0.52] to approximate the volume of spheroid. Tumor burden per mouse was calculated as the sum of the volumes of all tumors per mouse. Statistical significance was determined by non-parametric T-test (Mann-Whitney) and p values of less than 0.05 were considered statistically significant.
###end p 52
###begin title 53
In vitro migration and invasion assays
###end title 53
###begin p 54
###xml 14 19 11 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 9 19 6 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bcl-x<sup>fl/fl</sup></italic>
###xml 69 78 66 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 85 90 82 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 80 90 77 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 534 535 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 959 960 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1058 1059 1031 1032 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1583 1584 1550 1551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1722 1723 1689 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1736 1741 1700 1705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1731 1741 1695 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 1810 1811 1774 1775 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2000 2005 1961 1966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1995 2005 1956 1966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sup>fl/fl</sup></italic>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 177 183 <span type="species:ncbi:9913">bovine</span>
###xml 820 826 <span type="species:ncbi:9913">bovine</span>
A betaTC bcl-xfl/fl cell line (#14731) was derived from a tumor of a RIP1-Tag2; Bcl-xfl/fl mouse. Briefly, the dissected tumor was disrupted in DMEM supplemented with 20% fetal bovine serum (FBS), penicillin/streptomycin, and fungizone and tumor cells were collected by gravity sedimentation. Cells were infected with either Ad-GFP or Ad-Cre-GFP (Vector Development Lab, Baylor College of Medicine) at a multiplicity of infection of approximately200. Approximately two weeks post-infection, cells were serum-starved overnight and 1x105 cells were seeded the next day in triplicate into BD BioCoat control trans-well inserts with 8-microm porous polyethelene terepththalate (PET) membranes (for migration assays) or Matrigel-coated invasion chambers (BD Biosciences). Cells were plated in serum-free DMEM containing 0.2% bovine serum albumin +/-100 microM cobalt chloride into the upper chambers and the lower chambers were filled with DMEM (+/-100 microM CoCl2) containing 10% FBS as a chemoattractant. Cells were incubated for 48 hours in a humidified 5% CO2/37degreesC incubator after which non-migrated/invaded cells were removed from the upper membrane and membranes were fixed and stained with 0.2% crystal violet. For quantitating migration, the mean number of migrating cells in eight, 10x fields was determined/membrane; for quantitating invasion, the total number of invading cells/membrane was counted (under 10x objective) due to the low number of invading cells. To determine whether differences in cell growth/survival as a result of reduced Bcl-x expression and/or CoCl2 treatment could be contributing to the migration/invasion results, in parallel with plating cells for the migration/invasion assays, 2x105 betaTC Bcl-xfl/fl cells +/-Ad-Cre were plated in triplicate in 24-well plates (+/-CoCl2) and cells were trypsinized and counted after 48 hrs. The migration/invasion and cell growth assays were repeated in three separate experiments. With each experiment, the same betaTC Bcl-xfl/fl cells +/-cre were also plated for generation of protein extracts to confirm reduced Bcl-x protein expression.
###end p 54
###begin title 55
Supporting Information
###end title 55
###begin p 56
###xml 240 244 <span type="species:ncbi:10090">mice</span>
Bcl-x expression is significantly reduced in Bclx-KO tumors. Quantitative RT-PCR (Taqman) was carried out on 1st strand cDNA synthesized from RNA isolated from individual tumors from RIP1-Tag2; RIP-Cre; Bcl-xfl/fl and RIP1-Tag2; Bcl-xfl/fl mice. A pan probe that detected all major anti-apoptotic splice variants was used. Gene expression was normalized to and plotted as a function of GUS (A) or L19 expression (B).
###end p 56
###begin p 57
(0.13 MB TIF)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 398 402 <span type="species:ncbi:10090">mice</span>
Expression of anti-apoptotic Bcl-2 family members during RIP1-Tag2 tumor development. mRNA levels of individual pro-survival Bcl-2 family members, Bcl-w, A1, Mcl-1 and Boo were assessed using quantitative RT-PCR (Taqman) on first strand cDNA synthesized from total RNA pools (4-6 animals per pool) of normal, non-transgenic islets, hyperplastic islets, angiogenic islets, and tumors from RIP1-Tag2 mice. Gene expression was normalized to and plotted as a percentage of GUS (A) or L19 expression (B).
###end p 59
###begin p 60
(0.22 MB TIF)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
Control Gene expression during RIP1-Tag2 tumor progression and in Bclx-w.t. and KO tumors. (A-C) mRNA levels were assessed using quantitative RT-PCR (Taqman) on first strand cDNA synthesized from total RNA pools (4-6 animals per pool) of normal, non-transgenic islets (N), hyperplastic islets (H), angiogenic islets (A), and tumors (T) from RIP1-Tag2 mice. Three distinct Taqman primer sets were used to detect GAPDH, GUS and L19. (D) Quantitative RT-PCR (Taqman) was carried out on 1st strand cDNA synthesized from RNA isolated from individual tumors from RIP1-Tag2; RIP-Cre; Bcl-xfl/fl and RIP1-Tag2; Bcl-xfl/fl mice.
###end p 62
###begin p 63
(0.18 MB TIF)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
###xml 881 890 881 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004455.s003">Figure S3</xref>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
Loss of Bcl-x does not elicit transcriptional up-regulation of other anti-apoptotic Bcl-2 family members. mRNA levels of individual pro-survival Bcl-2 family members, Bcl-x, Bcl-2, Bcl-w, A1, Mcl-1 and Boo were assessed using quantitative RT-PCR (Taqman) on first strand cDNA synthesized from total RNA isolated from individual tumors from RIP1-Tag2; RIP-Cre; Bcl-xfl/fl mice (n = 9 tumors from 5 distinct mice; 1 tumor found to not express Cre and exhibit wild-type levels of Bcl-x excluded from these data) and RIP1-Tag2; Bcl-xfl/fl mice (n = 10 tumors from 5 individual mice). Relative gene expression was normalized to and presented as a percentage of GUS (A) or L19 (B) expression. The apparent up-regulation of bcl-w and mcl-1 when normalized to L19 expression does not represent an actual change in Bcl-2 family member expression but rather lower level of L19 in KO tumors (Figure S3). Data represents Mean+/-SEM. Statistical significance determined by non-parametric T-test (Mann-Whitney). P<0.05 considered significant.
###end p 65
###begin p 66
(0.20 MB TIF)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
Loss of Bcl-x expression results in an altered proportion of adenomas/carcinomas. Tumors on H&E sections from 13 wk RIP1-Tag2; Bcl-xfl/fl (n = 46 tumors from 5 mice) and RIP1-Tag2; RIP-Cre; Bcl-xfl/fl mice (n = 35 tumors from 5 mice) were scored as either non-invasive islet tumors/adenomas (IT), micro-invasive carcinomas (type 1; IC1), or highly invasive carcinomas (type 2; IC2) and the proportion of tumors in each class was calculated. p = 0.04, Chi-squared test for independence, comparing distribution of tumor types between the two groups of mice.
###end p 68
###begin p 69
(0.12 MB TIF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
We thank Ehud Drori, Susan Cacacho, Marina Vayner, and Cherry Concengco for excellent technical assistance, the UCSF Cancer Center Genome Facility for Taqman analysis and the UCSF Diabetes and Endocrinology Research Center Microscopy and Imaging Core for use of their brightfield microscope and histology equipment.
###end p 71
###begin title 72
References
###end title 72
###begin article-title 73
The hallmarks of cancer.
###end article-title 73
###begin article-title 74
Normal ras genes: their onco-suppressor and pro-apoptotic functions (review).
###end article-title 74
###begin article-title 75
A matter of life and cell death.
###end article-title 75
###begin article-title 76
Intrinsic tumour suppression.
###end article-title 76
###begin article-title 77
Apoptosis and tumourigenesis.
###end article-title 77
###begin article-title 78
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia.
###end article-title 78
###begin article-title 79
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
###end article-title 79
###begin article-title 80
###xml 39 61 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2.
###end article-title 80
###begin article-title 81
###xml 0 10 <span type="species:ncbi:6239">C. elegans</span>
C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2.
###end article-title 81
###begin article-title 82
The Bcl2 family: regulators of the cellular life-or-death switch.
###end article-title 82
###begin article-title 83
BCL2 family of apoptosis-related genes: functions and clinical implications in cancer.
###end article-title 83
###begin article-title 84
The Bcl-2 protein family: arbiters of cell survival.
###end article-title 84
###begin article-title 85
###xml 55 70 <span type="species:ncbi:10090">transgenic mice</span>
###xml 102 117 <span type="species:ncbi:10633">simian virus 40</span>
Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.
###end article-title 85
###begin article-title 86
###xml 53 68 <span type="species:ncbi:10090">transgenic mice</span>
Molecular dissection of multi-stage tumorigenesis in transgenic mice.
###end article-title 86
###begin article-title 87
The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.
###end article-title 87
###begin article-title 88
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis.
###end article-title 88
###begin article-title 89
###xml 66 81 <span type="species:ncbi:10090">transgenic mice</span>
###xml 108 112 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Coordinate expression of the endogenous p53 gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes.
###end article-title 89
###begin article-title 90
A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.
###end article-title 90
###begin article-title 91
Insulin-like growth factor II is focally up-regulated and functionally involved as a second signal for oncogene-induced tumorigenesis.
###end article-title 91
###begin article-title 92
Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.
###end article-title 92
###begin article-title 93
###xml 20 25 <span type="species:ncbi:9606">human</span>
Identification of a human cDNA encoding a novel Bcl-x isoform.
###end article-title 93
###begin article-title 94
###xml 22 25 <span type="species:ncbi:10116">rat</span>
An additional form of rat Bcl-x, Bcl-xbeta, generated by an unspliced RNA, promotes apoptosis in promyeloid cells.
###end article-title 94
###begin article-title 95
###xml 53 56 <span type="species:ncbi:10116">rat</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas.
###end article-title 95
###begin article-title 96
Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.
###end article-title 96
###begin article-title 97
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis.
###end article-title 97
###begin article-title 98
VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.
###end article-title 98
###begin article-title 99
Boo, a novel negative regulator of cell death, interacts with Apaf-1.
###end article-title 99
###begin article-title 100
Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.
###end article-title 100
###begin article-title 101
###xml 88 93 <span type="species:ncbi:9606">human</span>
BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells.
###end article-title 101
###begin article-title 102
Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1.
###end article-title 102
###begin article-title 103
BCL-2-induced glioma cell invasiveness depends on furin-like proteases.
###end article-title 103
###begin article-title 104
###xml 68 73 <span type="species:ncbi:10090">Mouse</span>
Assessing Tumor Progression Factors by Somatic Gene Transfer into a Mouse Model: Bcl-xL Promotes Islet Tumor Cell Invasion.
###end article-title 104
###begin article-title 105
Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression.
###end article-title 105
###begin article-title 106
Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.
###end article-title 106
###begin article-title 107
Hypoxic regulation of metastasis via hypoxia-inducible factors.
###end article-title 107
###begin article-title 108
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.
###end article-title 108
###begin article-title 109
Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction.
###end article-title 109
###begin article-title 110
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.
###end article-title 110
###begin article-title 111
###xml 56 59 <span type="species:ncbi:8790">Emu</span>
Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma.
###end article-title 111
###begin article-title 112
###xml 44 59 <span type="species:ncbi:10090">transgenic mice</span>
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
###end article-title 112
###begin article-title 113
An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
###end article-title 113
###begin article-title 114
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.
###end article-title 114
###begin article-title 115
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.
###end article-title 115
###begin article-title 116
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
###end article-title 116
###begin article-title 117
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737.
###end article-title 117
###begin article-title 118
Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.
###end article-title 118
###begin article-title 119
Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly.
###end article-title 119
###begin article-title 120
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma.
###end article-title 120
###begin article-title 121
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.
###end article-title 121
###begin p 122
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 122
###begin p 123
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by the A.P. Giannini Foundation for Medical Research (D.B.U), The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (L.H.), and grants from the National Cancer Institute (D.H.; R01CA45234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 123

